GE Healthcare Technologies IncNASDAQ:GEHC
- LAST PRICE89.9300
- TODAY'S CHANGE (%)1.4000 (1.5814%)
- Bid / Lots89.9100/ 1
- Ask / Lots89.9500/ 1
- Open / Previous Close89.6700 / 88.5300
- Day Range
- 52 Week Range
- Volume723,927
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GEHC |
|---|---|---|
| 09:32 ET | 33738 | 88.95 |
| 09:34 ET | 12553 | 89.05 |
| 09:36 ET | 15983 | 89.0523 |
| 09:38 ET | 2460 | 88.79 |
| 09:39 ET | 9811 | 89.49 |
| 09:41 ET | 6474 | 89.375 |
| 09:43 ET | 4317 | 89.38 |
| 09:45 ET | 4784 | 89.49 |
| 09:48 ET | 12143 | 89.69 |
| 09:50 ET | 17994 | 89.798 |
| 09:52 ET | 13450 | 89.505558 |
| 09:54 ET | 9713 | 89.42 |
| 09:56 ET | 9630 | 89.14 |
| 09:57 ET | 20663 | 89.503 |
| 09:59 ET | 3477 | 89.57 |
| 10:01 ET | 8909 | 89.55 |
| 10:03 ET | 15075 | 89.69 |
| 10:06 ET | 9599 | 89.7 |
| 10:08 ET | 6256 | 89.66 |
| 10:10 ET | 5938 | 89.59 |
| 10:12 ET | 10412 | 89.54 |
| 10:14 ET | 5631 | 89.73 |
| 10:15 ET | 5512 | 89.72 |
| 10:17 ET | 7533 | 89.72 |
| 10:19 ET | 14237 | 89.96 |
| 10:21 ET | 58941 | 90.09 |
| 10:24 ET | 6785 | 90.15 |
| 10:26 ET | 4800 | 90.215 |
| 10:28 ET | 5635 | 90.3004 |
| 10:30 ET | 23284 | 90.36 |
| 10:32 ET | 12234 | 90.3804 |
| 10:33 ET | 6616 | 90.34 |
| 10:35 ET | 3837 | 90.455 |
| 10:37 ET | 15999 | 90.505 |
| 10:39 ET | 3382 | 90.345 |
| 10:42 ET | 3901 | 90.34 |
| 10:44 ET | 4458 | 90.17 |
| 10:46 ET | 4838 | 90.26 |
| 10:48 ET | 4382 | 90.19 |
| 10:50 ET | 4472 | 90.08 |
| 10:51 ET | 3743 | 89.99 |
| 10:53 ET | 3903 | 89.885 |
| 10:55 ET | 3409 | 90.005 |
| 10:57 ET | 2828 | 89.96 |
| 11:00 ET | 3260 | 89.93 |
| 11:02 ET | 4265 | 89.83 |
| 11:04 ET | 1519 | 89.87 |
| 11:06 ET | 3961 | 89.94 |
| 11:08 ET | 5222 | 89.92 |
| 11:09 ET | 3119 | 89.77 |
| 11:11 ET | 3676 | 89.91 |
| 11:13 ET | 3665 | 89.93 |
Today
Yesterday
Press Release: GE HealthCare announces cash dividend for third quarter of 2024, from 18 hours ago by Dow Jones
18 hours ago by Dow JonesGE HealthCare announces cash dividend for third quarter of 2024, from 18 hours ago by Dow Jones
18 hours ago by Dow JonesDJ GE HealthCare Stock Is Rising. Why One Analyst Says Buy. -- Barrons.com, from 9:02AM ET on Wednesday Sep 18, 2024 by Dow Jones
9:02AM ET on Wednesday Sep 18, 2024 by Dow JonesDJ GE Hlthcr Techs Raised to Buy From Neutral by BTIG, from 7:34AM ET on Wednesday Sep 18, 2024 by Dow Jones
7:34AM ET on Wednesday Sep 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
GE Healthcare Technologies Inc | 40.4B | 26.0x | --- |
Koninklijke Philips NV | 29.0B | -45.4x | --- |
Agilent Technologies Inc | 39.9B | 29.5x | +9.42% |
Edwards Lifesciences Corp | 40.7B | 28.3x | +14.85% |
Resmed Inc | 35.0B | 34.8x | +19.48% |
Veeva Systems Inc | 34.9B | 56.4x | +17.29% |
Company Information
GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.
Contact Information
- Headquarters
- 500 West Monroe StreetCHICAGO, IL, United States 60661
- Phone
- 203-360-4369
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- H. Lawrence Culp
- President, Chief Executive Officer, Director
- Peter Arduini
- Chief Financial Officer, Vice President
- James Saccaro
- Chief Executive Officer - Pharmaceutical Diagnostics
- Kevin O'Neill
- Chief Executive Officer - Ultrasound
- Roland Rott
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.4B |
|---|---|
Revenue (TTM) | $19.5B |
Shares Outstanding | 456.7M |
Dividend Yield | 0.13% |
Annual Dividend Rate | 0.1200 USD |
Ex-Dividend Date | 07-19-24 |
Pay Date | 08-15-24 |
Beta | --- |
EPS | $3.45 |
Book Value | $15.67 |
P/E Ratio | 26.0x |
Price/Sales (TTM) | 2.1 |
Price/Cash Flow (TTM) | 18.2x |
Operating Margin | 12.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
